Karyopharm Therapeutics Inc. (KPTI)
NASDAQ·Healthcare·Biotechnology
$1.72
-5.49%
Mkt Cap $38.53M
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (16 analysts)
$13.20
Range $3.00 – $28.00
Implied Upside
+667.4%
Consensus $13.20 vs current $1.72
NASDAQ·Healthcare·Biotechnology
$1.72
-5.49%
Mkt Cap $38.53M
Buy
4
Hold
1
Sell
0
Price Target (16 analysts)
$13.20
Range $3.00 – $28.00
+667.4%
Consensus $13.20 vs current $1.72